ArisGlobal Unveils Groundbreaking XDI NavaX Data Intelligence and New Tools to Enhance AI Across Life Sciences
ArisGlobal, a prominent technology company specializing in artificial intelligence (AI) and a leader in the life sciences sector, has made a significant announcement during its annual industry event, Breakthrough 2026, held in Madrid, Spain. The company has introduced five major updates aimed at enhancing the operationalization of AI across various functions. The highlight of the announcement was the unveiling of XDI (eXplainable Data Intelligence), a next-generation data intelligence cortex designed to facilitate consistent and explainable decision-making across research and development in the pharmaceutical industry.
XDI differentiates itself from conventional tools that primarily speed up workflow stages. Instead, it provides a system-agnostic foundation that integrates meaning, context, and intent across the organization. This ensures that decisions in safety, regulatory, clinical, quality, and manufacturing areas are based on a unified understanding, aligned evidence, and standardized governance. Such an approach will not only promote the adoption and implementation of AI but also minimize risks and interpretative discrepancies among teams and use cases.
In addition to XDI, ArisGlobal has expanded its NavaX Agents Suite with three innovative agents specifically designed to enhance intelligence in regulatory affairs, change distribution, and signal processing.
Furthermore, ArisGlobal has integrated certified translation capabilities into its data case admission workflows, thanks to a strategic partnership with TransPerfect Life Sciences. The technology allows for intelligent language detection, which promptly redirects non-English safety forms for translation by industry-specific language models and expert linguists. This seamless API integration returns translated forms directly to LifeSphere, significantly reducing manual effort and accelerating global pharmacovigilance processes. By integrating the NavaX and TransPerfect platforms, translation management time has drastically decreased from approximately five hours to less than one minute per case, delivering unparalleled automation, speed, and accuracy to the market.
Aman Wasan, CEO of ArisGlobal, emphasized, "The challenge for life sciences is not just the adoption of AI, but implementing it at scale consistently, with governance and a tangible business impact. With these product enhancements, we continue to empower organizations to move from experimentation to production, establishing AI as a reliable foundation for decision-making."
Ann-Marie Orange, CIO and Global R&D Director of ArisGlobal, added, "We are witnessing a fundamental shift in how technology empowers life sciences teams. These innovations represent an evolution from automating individual tasks to orchestrating intelligence across entire operational ecosystems, enabling smarter decisions and faster insights while supporting truly scalable AI adoption."
Breakthrough 2026 is designed to bring together top executives, industry leaders, and experts to explore themes around the operationalization of AI, showcasing how proven AI use cases are being transformed into daily practice within life sciences.
For further information, you can visit ArisGlobal's website or follow them on LinkedIn.
ArisGlobal is a leading life sciences technology company offering cloud-based software solutions for pharmacovigilance, regulatory affairs, quality management, and medical affairs. The company's unified platform, LifeSphere®, combines industry expertise, advanced technology, and analytics to help life sciences organizations turn regulatory compliance into a strategic advantage. Serving over 300 clients worldwide, including many of the leading pharmaceutical, biotechnology, and medical device companies, ArisGlobal continues to shape the future of life sciences technology. For more information, visit www.arisglobal.com.
XDI: A New Era of Data Intelligence
XDI differentiates itself from conventional tools that primarily speed up workflow stages. Instead, it provides a system-agnostic foundation that integrates meaning, context, and intent across the organization. This ensures that decisions in safety, regulatory, clinical, quality, and manufacturing areas are based on a unified understanding, aligned evidence, and standardized governance. Such an approach will not only promote the adoption and implementation of AI but also minimize risks and interpretative discrepancies among teams and use cases.
Introducing New Agents for Enhanced Regulatory Intelligence
In addition to XDI, ArisGlobal has expanded its NavaX Agents Suite with three innovative agents specifically designed to enhance intelligence in regulatory affairs, change distribution, and signal processing.
- - Intelligence Agents: These agents improve submission quality by interpreting regulatory guidelines into precise compliance checklists. They automatically evaluate submissions made through LifeSphere, providing clear compliance assessments, justifications, and trust scores.
- - Distribution Agents: This tool continuously validates compliance by automatically incorporating evolving regulatory guidelines. It ensures that internal distribution logic is adhered to and initiates governed change workflows whenever discrepancies arise.
- - Signals Agents: Working as an intelligent assistant, these agents interpret user intentions and recommend the best analytical approaches. They dynamically plan and execute workflows, utilizing an orchestration layer based on reasoning that encompasses safety, data, analysis, and expert judgment.
NavaX Translation: Streamlining Global Data Workflows
Furthermore, ArisGlobal has integrated certified translation capabilities into its data case admission workflows, thanks to a strategic partnership with TransPerfect Life Sciences. The technology allows for intelligent language detection, which promptly redirects non-English safety forms for translation by industry-specific language models and expert linguists. This seamless API integration returns translated forms directly to LifeSphere, significantly reducing manual effort and accelerating global pharmacovigilance processes. By integrating the NavaX and TransPerfect platforms, translation management time has drastically decreased from approximately five hours to less than one minute per case, delivering unparalleled automation, speed, and accuracy to the market.
Driving Change within Life Sciences
Aman Wasan, CEO of ArisGlobal, emphasized, "The challenge for life sciences is not just the adoption of AI, but implementing it at scale consistently, with governance and a tangible business impact. With these product enhancements, we continue to empower organizations to move from experimentation to production, establishing AI as a reliable foundation for decision-making."
Ann-Marie Orange, CIO and Global R&D Director of ArisGlobal, added, "We are witnessing a fundamental shift in how technology empowers life sciences teams. These innovations represent an evolution from automating individual tasks to orchestrating intelligence across entire operational ecosystems, enabling smarter decisions and faster insights while supporting truly scalable AI adoption."
Breakthrough 2026 is designed to bring together top executives, industry leaders, and experts to explore themes around the operationalization of AI, showcasing how proven AI use cases are being transformed into daily practice within life sciences.
For further information, you can visit ArisGlobal's website or follow them on LinkedIn.
About ArisGlobal
ArisGlobal is a leading life sciences technology company offering cloud-based software solutions for pharmacovigilance, regulatory affairs, quality management, and medical affairs. The company's unified platform, LifeSphere®, combines industry expertise, advanced technology, and analytics to help life sciences organizations turn regulatory compliance into a strategic advantage. Serving over 300 clients worldwide, including many of the leading pharmaceutical, biotechnology, and medical device companies, ArisGlobal continues to shape the future of life sciences technology. For more information, visit www.arisglobal.com.
Topics Consumer Technology）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.